6 Trademark Results found for "opV*"

Also try searching for:

*opV

Details	Status	Class/Description
OPVIKA WUHAN NEUROPHTH BIOTECHNOLOGY LIMITED COMPANY 2203387 2 Jun 2022	ABANDONED SECTION 36 on 29 Aug 2024	Pharmaceutical preparations; medicines for human purposes; biological ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations; medicines for human purposes; biological preparations for veterinary purposes; drugs for medical purposes; ophthalmic preparations; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular surgery; ophthalmic pharmaceutical products.
OPVEE OPIANT PHARMACEUTICALS INC. 2173493 17 Mar 2022	REGISTERED on 13 Sept 2023	Pharmaceutical products, namely, pharmaceutical preparations for treat... Class 005 Class 005 Pharmaceutical Products Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparation, namely, an opioid antagonist
OPVOZIAD GLAXO GROUP LIMITED 2120807 29 Apr 2021	REGISTERED on 22 Feb 2023	Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy.
OPVOYUS BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1794162 3 Aug 2016	REGISTERED on 1 Aug 2019	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection, hepatitis; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents
OPVIZOR ICOMASOFT AG 1528400 19 May 2011	ABANDONED SECTION 36 on 23 Dec 2014	Computer software and computer software platforms for the operation of... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software and computer software platforms for the operation of a software distribution model in the internet, in particular for software-as-a-service applications for datacenters and for IT infrastructure provided over a network and customized to the needs of the users (cloud computing); computer software to participate in a decentralized data storage system and to publish data and to share access to data; computer software for error predictive analysis and issue prevention as well as display of possible solutions in the IT infrastructure; computer software for log file analysis and reports of respective results; computer software for overview of installed and operated infrastructure components in datacenters; computer software for exchange of infrastructure data with other users; computer software to bring together solution providers with users seeking solutions; computer software for logical connections of datacenter components within software-as-a-service applications, in particular of storage units, network components, file servers and software applications; computer software for data management, data processing, mobile solutions, data migration, data archiving, data destruction (data decommissioning), data cleansing, combining data from different sources into a target database (ETL); databases, namely hardware and software for organizing, storing and accessing data. Class 035 Class 035 Advertising, Business & Retail Services Providing access to databases; providing access to computer networks, internet platforms, databases and electronic publications; providing access to global computer networks and computer databases; provision of remote data access (telecommunications services); rental of access time to an electronic information platform (website) for the digital information gathering, management and storage; services of an internet provider, namely provision of access to digital networks, data networks and computer networks (in particular the internet); Computer services, namely design, engineering, preparation, installation, integration, maintenance and rental of computer software in data networks, in particular on the internet and World Wide Web, and providing of internet platforms for the operation of a software distribution model on the internet, especially software-as-a-service applications for datacenters; planning and design of heterogeneous networks (connecting individual computers and computer systems and their software components by means of telecommunication); computer science services of installation and maintenance of networks (software); computer systems analysis and analysis of computer data; installation, integration, support, assembly, maintenance, leasing, updating, outsourcing and maintenance of computer software; provision of non-downloadable software by means of telecommunication; provision or rental of electronic storage (web space) on the internet; rental of web servers; provision of application capacity and data storage, data management, data processing, data queries and test data for others through the internet or other communication networks (application service provider, software-as-a-service and data warehousing); rental and maintenance of storage space for use as websites for others (hosting). ... Class 038 Communications Services Class 039 Transportation & Storage Services Class 042 Computer & Software Services & Scientific Services
OPVEST DESJARDINS SÉCURITÉ FINANCIÈRE COMPAGNIE D'ASSURANCE VIE 1017989 7 Jun 1999	CANCELLED BY OWNER on 2 Dec 2015	Service de gestion d'actif et de passif mobilier et immobilier et nomm... Class 035 Class 035 Advertising, Business & Retail Services Class 036 Class 036 Insurance & Financial Services Service de gestion d'actif et de passif mobilier et immobilier et nommément i) acquérir et vendre tous titres mobiliers et tous biens immobiliers, ii) gérer des portefeuilles comprenant des éléments d'actif mobilier et immobilier, iii) gérer des portefeuilles financiers, iv) gérer des immeubles, v) gérer des biens mobiliers, vi) effectuer des placements sous toutes ses formes et notamment en valeurs mobilières ou en biens immobiliers.

ABANDONED SECTION 36

on 29 Aug 2024

OPVIKA

WUHAN NEUROPHTH BIOTECHNOLOGY LIMITED COMPANY

2203387 · 2 Jun 2022

005

Pharmaceutical preparations; medicines for human purposes; biological ...

REGISTERED

on 13 Sept 2023

OPVEE

OPIANT PHARMACEUTICALS INC.

2173493 · 17 Mar 2022

005

Pharmaceutical products, namely, pharmaceutical preparations for treat...

REGISTERED

on 22 Feb 2023

OPVOZIAD

GLAXO GROUP LIMITED

2120807 · 29 Apr 2021

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy.

Pharmaceutical preparations for use as anti-infectives; pharmaceutical...

REGISTERED

on 1 Aug 2019

OPVOYUS

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1794162 · 3 Aug 2016

005

Pharmaceutical preparations for human use for the treatment and preven...

ABANDONED SECTION 36

on 23 Dec 2014

OPVIZOR

ICOMASOFT AG

1528400 · 19 May 2011

009

035

...

Computer software and computer software platforms for the operation of...

CANCELLED BY OWNER

on 2 Dec 2015

OPVEST

DESJARDINS SÉCURITÉ FINANCIÈRE COMPAGNIE D'ASSURANCE VIE

1017989 · 7 Jun 1999

035

036

Service de gestion d'actif et de passif mobilier et immobilier et nomm...

Owners

Bristol-myers squibb company (a delaware corporation) (1)

Desjardins sécurité financière compagnie d'assurance vie (1)

Glaxo group limited (1)

Icomasoft ag (1)

Opiant pharmaceuticals inc. (1)

Wuhan neurophth biotechnology limited company (1)

Categories

Class 5 (4)

Class 35 (2)

Class 9 (1)

Class 36 (1)

Class 38 (1)

Class 39 (1)

Class 42 (1)

Correspondents

Gowling wlg (canada) llp (2)

Borden ladner gervais llp (1)

Robic agence pi s.E.C./ robic ip agency lp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

C$500/ 1 class + gov fee

United States

C$137/ 1 class + gov fee

Canada

C$500/ 1 class + gov fee

Mexico

C$691/ 1 class + gov fee

European Union

C$969/ 1 class + gov fee

China

C$691/ 1 class + gov fee

South Korea

C$967/ 1 class + gov fee

Japan

C$1,106/ 1 class + gov fee

India

C$345/ 1 class + gov fee

United Kingdom

C$691/ 1 class + gov fee

Australia

C$414/ 1 class + gov fee

Israel

C$967/ 1 class + gov fee

United Arab Emirates

C$967/ 1 class + gov fee

New Zealand

C$552/ 1 class + gov fee

Brazil

C$691/ 1 class + gov fee

Taiwan

C$1,106/ 1 class + gov fee

Ukraine

C$1,106/ 1 class + gov fee

Indonesia

C$967/ 1 class + gov fee

South Africa

C$691/ 1 class + gov fee

Singapore

C$1,106/ 1 class + gov fee

Saudi Arabia

C$1,106/ 1 class + gov fee

Afghanistan

C$1,106/ 1 class + gov fee

Algeria

C$1,106/ 1 class + gov fee

Argentina

C$552/ 1 class + gov fee

Austria

C$1,244/ 1 class + gov fee

Bahrain

C$967/ 1 class + gov fee

Bangladesh

C$829/ 1 class + gov fee

Benelux

C$1,382/ 1 class + gov fee

Bhutan

C$1,244/ 1 class + gov fee

Bolivia

C$1,106/ 1 class + gov fee

Botswana

C$1,797/ 1 class + gov fee

British Virgin Islands

C$1,659/ 1 class + gov fee

Bulgaria

C$1,106/ 1 class + gov fee

Cambodia

C$1,106/ 1 class + gov fee

Chile

C$691/ 1 class + gov fee

Colombia

C$967/ 1 class + gov fee

Congo

C$1,659/ 1 class + gov fee

Costa Rica

C$1,244/ 1 class + gov fee

Croatia

C$1,244/ 1 class + gov fee

Cyprus

C$1,382/ 1 class + gov fee

Czech Republic

C$1,244/ 1 class + gov fee

Denmark

C$1,106/ 1 class + gov fee

Aruba

C$1,659/ 1 class + gov fee

Dominican Republic

C$1,244/ 1 class + gov fee

Curacao

C$1,659/ 1 class + gov fee

Macau

C$967/ 1 class + gov fee

Greenland

C$1,106/ 1 class + gov fee

Ecuador

C$1,106/ 1 class + gov fee

Egypt

C$967/ 1 class + gov fee

El Salvador

C$1,106/ 1 class + gov fee

Ethiopia

C$1,520/ 1 class + gov fee

France

C$1,244/ 1 class + gov fee

Gaza

C$1,106/ 1 class + gov fee

Germany

C$1,244/ 1 class + gov fee

Greece

C$1,106/ 1 class + gov fee

Guatemala

C$1,244/ 1 class + gov fee

Haiti

C$1,244/ 1 class + gov fee

Honduras

C$1,244/ 1 class + gov fee

Hong Kong (SAR)

C$1,244/ 1 class + gov fee

Hungary

C$1,520/ 1 class + gov fee

Iraq

C$2,074/ 1 class + gov fee

Italy

C$1,244/ 1 class + gov fee

Jordan

C$1,106/ 1 class + gov fee

Kazakhstan

C$1,106/ 1 class + gov fee

Kenya

C$1,244/ 1 class + gov fee

Kuwait

C$1,106/ 1 class + gov fee

Laos

C$967/ 1 class + gov fee

Lebanon

C$1,382/ 1 class + gov fee

Lesotho

C$1,659/ 1 class + gov fee

Libya

C$1,244/ 1 class + gov fee

Madrid Protocol (WIPO)

C$2,765/ 1 class + gov fee

Malawi

C$1,520/ 1 class + gov fee

Malaysia

C$967/ 1 class + gov fee

Maldives

C$1,382/ 1 class + gov fee

Morocco

C$1,382/ 1 class + gov fee

Mozambique

C$1,244/ 1 class + gov fee

Myanmar

C$1,106/ 1 class + gov fee

Namibia

C$1,106/ 1 class + gov fee

Nepal

C$967/ 1 class + gov fee

Nicaragua

C$1,244/ 1 class + gov fee

Norway

C$1,244/ 1 class + gov fee

Oman

C$1,520/ 1 class + gov fee

Pakistan

C$1,106/ 1 class + gov fee

Panama

C$1,244/ 1 class + gov fee

Paraguay

C$1,244/ 1 class + gov fee

Peru

C$1,106/ 1 class + gov fee

Philippines

C$1,244/ 1 class + gov fee

Poland

C$691/ 1 class + gov fee

Portugal

C$1,244/ 1 class + gov fee

Puerto Rico

C$1,244/ 1 class + gov fee

Qatar

C$1,106/ 1 class + gov fee

Romania

C$1,244/ 1 class + gov fee

Serbia

C$1,244/ 1 class + gov fee

Slovakia

C$1,244/ 1 class + gov fee

Spain

C$1,244/ 1 class + gov fee

Sri Lanka

C$967/ 1 class + gov fee

Swaziland

C$1,797/ 1 class + gov fee

Sweden

C$1,106/ 1 class + gov fee

Switzerland

C$1,244/ 1 class + gov fee

Thailand

C$1,106/ 1 class + gov fee

Tunisia

C$1,244/ 1 class + gov fee

Turkey

C$1,106/ 1 class + gov fee

Uganda

C$967/ 1 class + gov fee

United Republic of Tanzania

C$967/ 1 class + gov fee

Uruguay

C$1,106/ 1 class + gov fee

Venezuela

C$1,244/ 1 class + gov fee

Vietnam

C$1,106/ 1 class + gov fee

West Bank, Palestine

C$1,106/ 1 class + gov fee

Yemen

C$2,350/ 1 class + gov fee

Albania

C$1,244/ 1 class + gov fee

Andorra

C$1,244/ 1 class + gov fee

Angola

C$1,797/ 1 class + gov fee

Antigua and Barbuda

C$1,659/ 1 class + gov fee

Armenia

C$1,106/ 1 class + gov fee

Azerbaijan

C$1,106/ 1 class + gov fee

Bahamas

C$1,935/ 1 class + gov fee

Barbados

C$1,797/ 1 class + gov fee

Belgium

C$1,382/ 1 class + gov fee

Belize

C$1,797/ 1 class + gov fee

Benin

C$1,106/ 1 class + gov fee

Bosnia and Herzegovina

C$1,382/ 1 class + gov fee

Brunei

C$1,797/ 1 class + gov fee

Burkina Faso

C$1,106/ 1 class + gov fee

Burundi

C$1,659/ 1 class + gov fee

Cabo Verde

C$1,244/ 1 class + gov fee

Cameroon

C$1,106/ 1 class + gov fee

Central African Republic (CAR)

C$1,106/ 1 class + gov fee

Chad

C$1,106/ 1 class + gov fee

Comoros

C$1,106/ 1 class + gov fee

Cote d'Ivoire

C$1,106/ 1 class + gov fee

Czechia

C$1,382/ 1 class + gov fee

Djibouti

C$1,659/ 1 class + gov fee

Dominica

C$1,797/ 1 class + gov fee

Equatorial Guinea

C$1,106/ 1 class + gov fee

Eritrea

C$1,382/ 1 class + gov fee

Estonia

C$1,797/ 1 class + gov fee

Eswatini

C$1,797/ 1 class + gov fee

Fiji

C$1,244/ 1 class + gov fee

Finland

C$967/ 1 class + gov fee

Gabon

C$1,106/ 1 class + gov fee

Gambia

C$1,244/ 1 class + gov fee

Georgia

C$1,106/ 1 class + gov fee

Ghana

C$1,382/ 1 class + gov fee

Grenada

C$1,797/ 1 class + gov fee

Guinea

C$1,106/ 1 class + gov fee

Guinea-Bissau

C$1,106/ 1 class + gov fee

Guyana

C$1,797/ 1 class + gov fee

Iceland

C$1,797/ 1 class + gov fee

Ireland

C$1,106/ 1 class + gov fee

Jamaica

C$1,659/ 1 class + gov fee

Kiribati

C$1,382/ 1 class + gov fee

Kosovo

C$1,244/ 1 class + gov fee

Kyrgyzstan

C$1,244/ 1 class + gov fee

Latvia

C$967/ 1 class + gov fee

Liberia

C$1,382/ 1 class + gov fee

Liechtenstein

C$1,382/ 1 class + gov fee

Lithuania

C$967/ 1 class + gov fee

Luxembourg

C$1,382/ 1 class + gov fee

Madagascar

C$1,382/ 1 class + gov fee

Mali

C$1,106/ 1 class + gov fee

Malta

C$829/ 1 class + gov fee

Marshall Islands

C$1,382/ 1 class + gov fee

Mauritania

C$1,106/ 1 class + gov fee

Mauritius

C$1,382/ 1 class + gov fee

Micronesia

C$1,382/ 1 class + gov fee

Moldova

C$1,382/ 1 class + gov fee

Monaco

C$1,935/ 1 class + gov fee

Mongolia

C$829/ 1 class + gov fee

Montenegro

C$1,244/ 1 class + gov fee

Nauru

C$1,382/ 1 class + gov fee

Netherlands

C$1,382/ 1 class + gov fee

Niger

C$1,106/ 1 class + gov fee

Nigeria

C$552/ 1 class + gov fee

North Macedonia

C$1,244/ 1 class + gov fee

Palau

C$1,382/ 1 class + gov fee

Palestine

C$1,382/ 1 class + gov fee

Papua New Guinea

C$1,106/ 1 class + gov fee

Rwanda

C$1,382/ 1 class + gov fee

Saint Kitts and Nevis

C$1,797/ 1 class + gov fee

Saint Lucia

C$1,797/ 1 class + gov fee

Saint Vincent and the Grenadines

C$1,797/ 1 class + gov fee

Samoa

C$1,659/ 1 class + gov fee

San Marino

C$1,382/ 1 class + gov fee

Sao Tome and Principe

C$1,382/ 1 class + gov fee

Senegal

C$1,106/ 1 class + gov fee

Seychelles

C$1,382/ 1 class + gov fee

Sierra Leone

C$1,382/ 1 class + gov fee

Slovenia

C$1,244/ 1 class + gov fee

Solomon Islands

C$1,382/ 1 class + gov fee

Somalia

C$1,382/ 1 class + gov fee

South Sudan

C$1,382/ 1 class + gov fee

Suriname

C$2,212/ 1 class + gov fee

Tajikistan

C$1,106/ 1 class + gov fee

Tanzania

C$967/ 1 class + gov fee

Timor-Leste

C$1,382/ 1 class + gov fee

Togo

C$1,106/ 1 class + gov fee

Tonga

C$1,797/ 1 class + gov fee

Trinidad and Tobago

C$1,659/ 1 class + gov fee

Turkmenistan

C$1,106/ 1 class + gov fee

Tuvalu

C$1,382/ 1 class + gov fee

Uzbekistan

C$967/ 1 class + gov fee

Vanuatu

C$1,659/ 1 class + gov fee

Zambia

C$1,244/ 1 class + gov fee

Zimbabwe

C$1,244/ 1 class + gov fee

OAPI

C$1,244/ 1 class + gov fee

ARIPO

C$1,382/ 1 class + gov fee

End of search results

Page 1 of 1